ã¡ãã£ã¢èšäº
ã€ãã«ã¡ã¯ãã³å人茞å
¥ã«èŠéãç§åŠçæ ¹æ ãªãã
ããºãææ°ããŒã¯ 1,334
twitterã³ã¡ã³ã 748ä»¶äž 1ïœ100件
ã¯ã¯ãã³ãã€ã¿ãŒãã³ãè¶äž»çŸ©è
å
±ããããä¿¡ä»°ããŠããã³ã¬ã
ã¯ã¯ãã³ãããã£ã¡ã®æ¹ãçåŸãªã®ã ãã
ã¯ã¯ãã³ãããã£ã¡ã®æ¹ãçåŸãªã®ã ãã
ç±³ã¡ã«ã¯ãéçºäžã®çµå£è¬ãšã€ãã«ã¡ã¯ãã³ã®æ§é ã®éããåæããŠæããŠã»ããã§ãããã»ãŒåããšãã話ããããŸããå¹æã¯ïŒïŒïŒ
ãã€ãã«ã®ïŒïŒïŒ
ã«å£ããŸããçç³»ã®èšè
ã«èšäºãæžããŠãããããã
äœãä¿¡ããã°è¯ãã®ã
ã¢ãªã«ã±æ¡ã®æ¿åºãäœã ã
ãç§åŠçæ ¹æ ãªãã
ã¢ãªã«ã±æ¡ã®æ¿åºãäœã ã
ãç§åŠçæ ¹æ ãªãã
沢山ã®æ¹ã
ãè¯ããªã£ãŠãã®ã«èªããªããã€ãïŒïŒ
ãã¯ã¯ãã³ã«ç§åŠçæ ¹æ ç¡ãã
ã³ããããžãã¹ããŸã å²ã足ããªãã®ãããããã°ããã³ããéšåã¯ç¶ããã ãª(;ÂŽÐŽïœ)
âã¡ã«ã¯ã¯ä»å¹ŽïŒæãæ°åã³ããææçã«å¯Ÿãããæ²»çå¹æã瀺ãç§åŠçãªæ ¹æ ã¯ç€ºãããŠããªãããšãã声æãçºè¡šãäžçä¿å¥æ©é¢ïŒïŒ·ïŒšïŒ¯ïŒã¯ïŒæâŠæçšã¯èšåºè©Šéšã«éå®ããããæ±ãããâ
é
·ãããã㊠åœå
ã§æ²»éšäžã ãããçµæãåºããŸã§æçšããªãããã«ãš åºæ¥ãªãã®ãïŒ
ææ¬ãçŸç°ã¯ããèšãéãåºæ¥ãªãã®ã§ã¯ã
è°å¡ã§ããããã©ãã©ãŒåŒè§£ããã®ïŒ
è°å¡ã§ããããã©ãã©ãŒåŒè§£ããã®ïŒ
ïŒ
ð å³éž

ð å³éž

ãã©ã·ãŒãå¹æã¯ãããããããªããã©ã( Ë-Ë )
人éã®ãæã蟌ã¿ãã£ãŠè¯ããæªããã¹ãŽãããã( Ë-Ë )
人éã®ãæã蟌ã¿ãã£ãŠè¯ããæªããã¹ãŽãããã( Ë-Ë )
倧å€ïŒå€§å€âŒïž
ããã©ãã¯ãŒããŸãã³ãã£ãšéšãããŠæ¡æ£ãããŠããããã«ã€ããŠå ±éãããŠããããããã
ééã£ãŠãã®ã¢ã«ãŠã³ããèŠããæ¹ã ã¯æ³šæããããããð€£
ããã©ãã¯ãŒããŸãã³ãã£ãšéšãããŠæ¡æ£ãããŠããããã«ã€ããŠå ±éãããŠããããããã
ééã£ãŠãã®ã¢ã«ãŠã³ããèŠããæ¹ã ã¯æ³šæããããããð€£
å人茞å
¥ã« ãç§åŠçæ ¹æ ãªãã
ã䜿çšèš±å¯ãèªããããæ±ããããšã§æ³šç®ãéããããåœå å€ã®èšåºè©Šéšã§æå¹æ§ã¯æããã«ãªã£ãŠããªãã
ã䜿çšèš±å¯ãèªããããæ±ããããšã§æ³šç®ãéããããåœå å€ã®èšåºè©Šéšã§æå¹æ§ã¯æããã«ãªã£ãŠããªãã
å
èšäºçœ®ããšããŸããâº
â»éœåã®æªãã³ã¡ã³ãå€æ°ã ãšããèšäºãæ¶ãããµãŒãããããã
â»éœåã®æªãã³ã¡ã³ãå€æ°ã ãšããèšäºãæ¶ãããµãŒãããããã
å»ççŸå Žã§ã䜿çšããããæèŠãå²ããŠããããšããµãŸããŠæ¬²ããã
ãã®ã³ã¡ã³ãæ¬åã!!
5000以äžã®ã³ã¡ã³ãã20000以äžã®ããã
åœã¯ã€ãã«ã¡ã¯ãã³ã«å¯Ÿããåœæ°ã®æèã®é«ããå®æããŠã»ããã
5000以äžã®ã³ã¡ã³ãã20000以äžã®ããã
åœã¯ã€ãã«ã¡ã¯ãã³ã«å¯Ÿããåœæ°ã®æèã®é«ããå®æããŠã»ããã
the importance of having the medical freedom to choose
ã¡ã«ã¯ç€Ÿã¯èªç€Ÿã®ã³ããçµå£è¬ã売ãããçºã«éã«ãªããªãã€ãã«ã¡ã¯ãã³ã¯ããã¯ãœã«æ¹å€ãããããã補è¬äŒç€Ÿã®éã
ã®ææäºé²ãæ²»çãç®çã«ãåœå
ã§æ¿èªãããŠããªãæå¯çè«è¬ãã€ãã«ã¡ã¯ãã³ããæµ·å€ããå人茞å
¥ããŠäœ¿çšããåããåºãã£ãŠããŸãããå°é家ã¯å人茞å
¥ã§ã®æçšã¯ããªãããèŠéã鳎ãããŠããŸãã
ãç§åŠçæ ¹æ ãªãããšããããçµéšçæ ¹æ ããããã§ããã
ãæå¹æ§ã確èªããããŠãªãïŒ
å€ãã®äººãèªèº«ã®äœéšã§ç¢ºèªããŠãŸããã
ãæå¹æ§ã確èªããããŠãªãïŒ
å€ãã®äººãèªèº«ã®äœéšã§ç¢ºèªããŠãŸããã
>ã¡ã«ã¯ã¯ä»å¹ŽïŒæãæ°åã³ããææçã«å¯Ÿãããæ²»çå¹æã瀺ãç§åŠçãªæ ¹æ ã¯ç€ºãããŠããªãããšãã声æãçºè¡šã
ã¡ãŒã«ãŒãå¹æããã£ãŠèšã£ãŠãã®ã«ãªãã§ä¿¡ããŠããã€å± ããã ãããã
ã¡ãŒã«ãŒãå¹æããã£ãŠèšã£ãŠãã®ã«ãªãã§ä¿¡ããŠããã€å± ããã ãããã
è«ãã蚌æ ïŒå®çžŸïŒïŒïŒ
ãã¯ããã
æ£æçåºé±ç®ç§åŠçµ±èšã§ãè¶ã ãå ¥ãããããªçžæã§ããªãããww
ãã¯ããã
æ£æçåºé±ç®ç§åŠçµ±èšã§ãè¶ã ãå ¥ãããããªçžæã§ããªãããww
ã€ãã«ã¡ã¯ãã³ã«å¹æãªããšèšãããŠããã®ã«æªã ã«æ€èšŒãšãèšã£ãŠãã奎ã£ãŠãªããªãã ãããããããã®ãããããã€ãã«ã¡ã¯ãã³ãè²·ãæ
匱ãå¢ããã®ã§ã¯ïŒ
åŒçš
ãã³ããã«å¯Ÿããå¹æã§è©±é¡æ²žéš°ïŒäžå®ææã§å£²ããŠãŸãïŒã
åŒçš
ãã³ããã«å¯Ÿããå¹æã§è©±é¡æ²žéš°ïŒäžå®ææã§å£²ããŠãŸãïŒã
ãã®èšäºã«æžã蟌ãŸããããæ°ã
ã®ã³ã¡ã³ãã¯èå³æ·±ãâ
説æãåŠå®ã®å
容ãã¯ã¯ãã³ãšäœãéãã®ãå
šãããããã
ãããéžæã«ããèªå·±è²¬ä»»ã¯å ±éã§ããïŒ
å°ãªããšãã€ãã«ã¡ã¯ãã³ã¯å®äœ¿çšãŸã§ã®æ®µéèžãã§ãããè¬ãšããŠã®æ ¹æ ã¯ã¯ã¯ãã³ããæãããããªãã®ïŒ
å¹ããå¹ããªããã¯ç¥ããªããããã¯äžç·ã ããã»ã£ãšãããïŒ
ãããéžæã«ããèªå·±è²¬ä»»ã¯å ±éã§ããïŒ
å°ãªããšãã€ãã«ã¡ã¯ãã³ã¯å®äœ¿çšãŸã§ã®æ®µéèžãã§ãããè¬ãšããŠã®æ ¹æ ã¯ã¯ã¯ãã³ããæãããããªãã®ïŒ
å¹ããå¹ããªããã¯ç¥ããªããããã¯äžç·ã ããã»ã£ãšãããïŒ
è¯ãåŸåã§ãããå€ãã®æ¹ãã¯ã¯ãã³è©æ¬ºã«æ°ã¥ããŠããã
å°é家ãç§åŠçæ ¹æ ãªãã
æ¬é³ãããã...ãã£ããéçºããã¡ãã¯ã®æ°è¬ã売ããªããªã£ãŠããŸããäœãããã³ãäžãã¯ãçµãã£ãŠããŸãã§ã¯ãªããð¢ð¢ðšã
æ¬é³ãããã...ãã£ããéçºããã¡ãã¯ã®æ°è¬ã売ããªããªã£ãŠããŸããäœãããã³ãäžãã¯ãçµãã£ãŠããŸãã§ã¯ãªããð¢ð¢ðšã
ç±³ããã©ã¹ã«å·åžæ³é·å®ãããããã·ã¯ãããã³ãã€ãã«ã¡ã¯ãã³ã®åŠæ¹èªãã
Doctors Can Prescribe Ivermectin, Hydroxychloroquine Off-Label for COVID-19: Nebraska AG
è¬ã¯ãã¹ãŠåæã ãšå²ãåãã°ããã³ãããïŒâ
èŠçŽããã¶ãŒïŒ
æ°åã³ãããŠã€ã«ã¹ã®ææäºé²ãæ²»çãç®çã«ãåœå ã§æ¿èªãããŠããªãæå¯çè«è¬ãåäººèŒžå ¥ããåããåºãã£ãŠãããåœå ã§ã¯é©å¿å€äœ¿çšãšããŠäžéšã®å»åž«ãåŠæ¹ããŠãããšãããå°é家ã¯ãåäººèŒžå ¥ã§ã®æçšã¯ããªãããã«ããšèŠéã鳎ãããŠããã
æ°åã³ãããŠã€ã«ã¹ã®ææäºé²ãæ²»çãç®çã«ãåœå ã§æ¿èªãããŠããªãæå¯çè«è¬ãåäººèŒžå ¥ããåããåºãã£ãŠãããåœå ã§ã¯é©å¿å€äœ¿çšãšããŠäžéšã®å»åž«ãåŠæ¹ããŠãããšãããå°é家ã¯ãåäººèŒžå ¥ã§ã®æçšã¯ããªãããã«ããšèŠéã鳎ãããŠããã
ããã®ã³ã¡ã³ãæ¬ãåã¯ã¯ãã³ã®äººã倧æããŠæŒãå¯ããŠãŠãªããªãã²ã©ãããšã«ãªã£ãŠãŸããã
30幎以äžãåããæ¥æ¬ã§äœ¿çšãããŠããã€ãã«ã¡ã¯ãã³
å¯äœçšãªããŠæ®ã©ãªã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹
ã ããç±ãªã©ãäžããŠããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©
ã¯ã¯ãã³åŸéºçã«ãæå¹
å¯äœçšãªããŠæ®ã©ãªã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹
ã ããç±ãªã©ãäžããŠããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©
ã¯ã¯ãã³åŸéºçã«ãæå¹
mRNAã¯ã¯ãã³ã®ç§åŠçæ ¹æ ãšãªã¿ãŒã³ã¯ãã£ãšãã£ãšãªããªã£ãŠããã
岞ç°ç·çãå±±é倧è£ãåŸè€å€§è£ãå å
倧è£ãæè€å€§è£
é ãäžç俯ç°
ä»®ã«ãä»å¹Žããã§ãåæã«ã€ãã«ã¡ã¯ãã³ãé åžããŠãããªããã®æ§ãªå€§æšäºãå ããŸãããååŽçæ¿åºã®è²¬ä»»ã¯å€§ãããäœååãç¹°ãè¿ããã€ããããŠãŸãã
é ãäžç俯ç°
ä»®ã«ãä»å¹Žããã§ãåæã«ã€ãã«ã¡ã¯ãã³ãé åžããŠãããªããã®æ§ãªå€§æšäºãå ããŸãããååŽçæ¿åºã®è²¬ä»»ã¯å€§ãããäœååãç¹°ãè¿ããã€ããããŠãŸãã
ã€ãã«ã¡ã¯ãã³ãã³ããã«å¹ããšããæåãªè«æã¯ããŸã®ãšããæé ã§åãäžããããŠãããã¡ãŒã«ãŒã®ã¡ã«ã¯ç€Ÿãæå¹æ§ãåŠå®ããŠããŸããããããªãã®ã§ãããïŒ
ããã®ããããã®å°ããã ãã¡ã¯æ ¹æ ã¯ïŒã£ãŠåŸ¹åºçã«ãããã©ããéã«å°ã£ãŠãªãã£ãããã£ãšããšããããªããããããªããããšã¯ãã¥ãŒã¹èšäºã¿ãã
ã«ã€ããŠã®å
æ¬çãªè«æ(ç§åŠçæ ¹æ å€æ°ãã)
ã€ãã«ã¡ã¯ãã³ããããäžççãªåããããåãããŸããã
ã€ãã«ã¡ã¯ãã³ããããäžççãªåããããåãããŸããã
å人茞å
¥ã£ãŠåœç©ãå±ãå¯èœæ§ããŒãã§ã¯ãªãã®ã«æããªããããª
ãããªã«ã€ãã«ã¡ã¯ãã³ã䜿ããããªãæ£åŒã«æ¿èªããããŸã§åŸ ãŠã°ããã®ã«
ãããªã«ã€ãã«ã¡ã¯ãã³ã䜿ããããªãæ£åŒã«æ¿èªããããŸã§åŸ ãŠã°ããã®ã«
èªå
¬æ¿æš©ã®ã€ãã«ã¡ã¯ãã³ã®èª¹è¬äžå·ã®äžäŸã§ã
ãªãæ¬ãå°çéããŠæ³£ãã
äŸã®äººã«ãã®ãã¥ãŒã¹æããŠãããã®ã«ããªãã®èšãèš³ã§èª€éåããã
ãªãã§ãä»ã«ãªã£ãŠâŠ
ãã»ãŒã®ã³ã¡æ¬ããã£ããå匷ãããŠãæ¹å€ããŠå®å¿( ËÍ áµ ËÍ )âš
30幎以äžãåããæ¥æ¬ã§äœ¿çšãããŠããã€ãã«ã¡ã¯ãã³
å¯äœçšãªããŠæ®ã©ãªã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹
ã ããç±ãªã©ãäžããŠããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©
ã³ããð解æ¯ã«ãæå¹
å¯äœçšãªããŠæ®ã©ãªã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹
ã ããç±ãªã©ãäžããŠããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©
ã³ããð解æ¯ã«ãæå¹
è©Šéšç®¡å®éšã£ãŠã
人éã¯è©Šéšç®¡ã®äžã§çããŠããèš³ã§ã¯ãªãã
ç§åŠçæ€èšŒã§æå¹æ§ã確èªãããŠããªãã«ãæããã
ã³ããã«å¹ææããšèšèŒã»è²©å£²ããæ¥è ããåãç· ãŸã察象ã§ãã
人éã¯è©Šéšç®¡ã®äžã§çããŠããèš³ã§ã¯ãªãã
ç§åŠçæ€èšŒã§æå¹æ§ã確èªãããŠããªãã«ãæããã
ã³ããã«å¹ææããšèšèŒã»è²©å£²ããæ¥è ããåãç· ãŸã察象ã§ãã
ç§ã®å人ã«ãã³ããã«ããã£ããšãçšã«åžžåããŠãã人ãäºäººããããã¡ããã¯ã¯ãã³ã¯æªæ¥çš®ã
äºäººãšãæŸå°è³ã
ãµãããšãå ±ç£å ã¯å«ããããªãã¿ã€ãã
äºäººãšãæŸå°è³ã
ãµãããšãå ±ç£å ã¯å«ããããªãã¿ã€ãã
ã²ã©ãèšäºãã€ãã³ã¡ã¯èšäºãšæ£å察ãã€ãã³ã¡ãçã£åœã§ãã
ã³ã¡ã³ãæ¬ãã²ã©ããæ¥æ¬èªèªããªã人å€ãã®ãâŠïŒå€§äžå€«âŠïŒ
ã€ãã«ã¡ã¯ãã³ã«éãããå»åž«â¢è¬å€åž«ã§ã¯ãªã人ãäœçšæ©åºãåããããè¬ãåæã«äœ¿ãæ¹ãå±éºã ããªããšæããã©ãããããã
ã€ãã«ã¡ã¯ãã³ã«éãããå»åž«â¢è¬å€åž«ã§ã¯ãªã人ãäœçšæ©åºãåããããè¬ãåæã«äœ¿ãæ¹ãå±éºã ããªããšæããã©ãããããã
@ Sankei_newsãã
ããããæ°èå®æã®äžçš®ã ãã "
ã¯ã¯ãã³ãã¹ããŒãã®ç§åŠçæ ¹æ ã¯ïŒ
ãããå人茞å
¥ããŠé倧äºæ
ãããããæ±äº¬éœã®å»åž«äŒã®å
çããã¬ãã§èšã£ãŠãããã ããªããŠèšãããããã©ããããããããªããŠãŸãå
ã
ãèããã®ãä»äºã®ãã¬ãŒãã³ã°ãªããã§ãã
>ãããªãã¯éŠ¬ã§ãçã§ããªããçãããæ¬åœã«ãããŠããšå®¶ççšã®æçšã«ç°äŸã®èŠåãåºããã
ðããããžãã®èã§ãé£ãããŠãã
ðããããžãã®èã§ãé£ãããŠãã
ãã¿ãã³ãäºéçã®ãµããªããã·ãªããŒã«å
¥éŒ»è
æŽæµãåã¹ãã¬ãŒã¯ãã«ã¿æ ªè延æã«æãããæµç³ã«ã€ãã«ã¡ã¯ãã³ã¯âŠå»è¬åã ãã
ææããŒã¯æã«èªå® çé€æ»!!ã£ãŠå ±éã§ææç œãéããªãã ãã
ð
ææããŒã¯æã«èªå® çé€æ»!!ã£ãŠå ±éã§ææç œãéããªãã ãã
ð
ã³ã¡ã³ãæ¬ã®æ¹ãé¢çœãã
ç§åŠçæ ¹æ ãšèšãã°mRNAã¯ã¯ãã³ã®å®å
šæ§ãååã«æ
ä¿ããããã®ã§ã¯ãªããããªãããã ãæ¯ãšè¬ã¯çŽäžéãå人人äœå®éšã«åå ããããšã¯æããªããª
30幎以äžãåããæ¥æ¬ã§äœ¿çšãããŠããã€ãã«ã¡ã¯ãã³ã
å¯äœçšãªããŠæ®ã©ãªãã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹
ã ããç±ãªã©ãäžããŠãããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©ã
å¯äœçšãªããŠæ®ã©ãªãã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹
ã ããç±ãªã©ãäžããŠãããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©ã
>åœå
å€ã§æå¹æ§ãå®å
šæ§ãæ€èšããè©Šéšãç 究ãç¶ããŠããããæ確ãªå¹æã¯ç€ºãããŠããªãã
ããããã
ã¯ã¯ãã³äžæãªãã ãã3åç®ãšèšããäœåã§ãè³¢ããªãããã«å°ã£ãã»ããè¯ããïŒ
ããããã
ã¯ã¯ãã³äžæãªãã ãã3åç®ãšèšããäœåã§ãè³¢ããªãããã«å°ã£ãã»ããè¯ããïŒ
ã³ã¡ã³ãæ¬ãåãããšã«ãªã£ãŠããâ
ã³ã¡ã³ãæ¬èŠãŠããšåããŠã人ããªãããã¿ããã ãªã
30幎以äžãåããæ¥æ¬ã§äœ¿çšãããŠããã€ãã«ã¡ã¯ãã³ã
å¯äœçšãªããŠæ®ã©ãªãã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹
ã ããç±ãªã©ãäžããŠãããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©ã
é·æ倱瀌ð
å¯äœçšãªããŠæ®ã©ãªãã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹
ã ããç±ãªã©ãäžããŠãããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©ã
é·æ倱瀌ð
30幎以äžãåããæ¥æ¬ã§äœ¿çšãããŠããã€ãã«ã¡ã¯ãã³ã
å¯äœçšãªããŠæ®ã©ãªãã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹ð
ã ããç±ãªã©ãäžããŠãããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©ã
å¯äœçšãªããŠæ®ã©ãªãã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹ð
ã ããç±ãªã©ãäžããŠãããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©ã
æšæ¥ã äžéã®ã³ã¡ã³ããªã©ãèªãã§ããŸããããã£ããåãæèŠã®äººãã³ã¡ã³ãã«ããã®ã§ãçããè²ã
ãªæ°£ã¥ããåŸãæ¹ãå¢ããŠãããªãšæããŸããã
èšäºã¯ãã¡ãã§ãã
èšäºã¯ãã¡ãã§ãã
æŸå°è³ãåã¯ã¯ãã³è³ãå
±éããŠããã®ã¯æ
匱ããã¹ããªãã¯çåå¿ã§ããªãã§ãããããå©ãããããé£ã³ã€ãããããããã人ãçã£å
ã«å€§æšäºã®æã«æ»ã¬ãšæããã
30幎以äžãåããæ¥æ¬ã§äœ¿çšãããŠããã€ãã«ã¡ã¯ãã³ã
å¯äœçšãªããŠæ®ã©ãªãã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹âš
ã ããç±ãªã©ãäžããŠãããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©ã
å¯äœçšãªããŠæ®ã©ãªãã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹âš
ã ããç±ãªã©ãäžããŠãããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©ã
30幎以äžãåããæ¥æ¬ã§äœ¿çšãããŠããã€ãã«ã¡ã¯ãã³ã
å¯äœçšãªããŠæ®ã©ãªãã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹ã
ã ããç±ãªã©ãäžããŠãããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©ã
å¯äœçšãªããŠæ®ã©ãªãã
é§è«è¬ã ããã¯ã¯ãã³ã«å«ãŸããå¯çè«ããŠã€ã«ã¹ã现èã«ãæå¹ã
ã ããç±ãªã©ãäžããŠãããã
äžæ¹åžè²©ã®è§£ç±å€ã¯è³ã麻çºãããŠç±ãäžãã£ãããã«èŠããããã ãã®ä»£ç©ã
å»åž«äŒãã€ãã«ã¡ã¯ãã³ã¯å¯çè«é§é€è¬ã ãã³ããã«ã¯å¹ããªãããšãã«åãã«å£°æ
15
>1
ã€ãã«ã¡ã¯ãã³ã®éçºè ã§ããŒãã«è³åè³ã®å€§æææãã³ããã«å¹ããšèšã£ãŠãã®ã ã
18
ããå¹ããŠãå²ãããªããã®ã売ããªãã ãw
15
>1
ã€ãã«ã¡ã¯ãã³ã®éçºè ã§ããŒãã«è³åè³ã®å€§æææãã³ããã«å¹ããšèšã£ãŠãã®ã ã
18
ããå¹ããŠãå²ãããªããã®ã売ããªãã ãw
æ®éã«åŠæ¹ããŠãããã°ãããã茞å
¥ããªããæ¿åºã誰ã®å³æ¹ãªã®ãïŒåŸææã¯åº¶æ°ããããïŒ
å»åŠçæ ¹æ ããªããããããå¹ããæãã®æ¹ã¯ããã£ããããŸã
éèŠãªã®ã¯
ã»äŸ¡æ ŒïŒé«äŸ¡ã§ããïŒãªã¹ã¯
ã»ãªã¹ã¯ãããã£ããã®è©äŸ¡
ã»åŒ·çãªå¯åå¿æã®è²¬ä»»ã®æåš
ã§ãã
éèŠãªã®ã¯
ã»äŸ¡æ ŒïŒé«äŸ¡ã§ããïŒãªã¹ã¯
ã»ãªã¹ã¯ãããã£ããã®è©äŸ¡
ã»åŒ·çãªå¯åå¿æã®è²¬ä»»ã®æåš
ã§ãã
æ¿åºâªåç§äŒâªååŽçã¯ãæ¥æ¬åœæ°ããè¬å€ã«ã€ããŠèª¿ã¹ãèããæ§ã«æã£ãããšã åãã§æ¬²ããã
ååŽç
念é¡ã®å»çè²»åæžã
å®çŸåºæ¥ãããå¥åº·ä¿éºèµ€åãçç±ã«ãã
å¢çšãäžèŠã«ãªã
WIN WINããð
ã€ãã«ã¡ã¯ãã³ã«éããã è¬ã«ã¯ãäœçšãšå¯äœçš
ååŽç
念é¡ã®å»çè²»åæžã
å®çŸåºæ¥ãããå¥åº·ä¿éºèµ€åãçç±ã«ãã
å¢çšãäžèŠã«ãªã
WIN WINããð
ã€ãã«ã¡ã¯ãã³ã«éããã è¬ã«ã¯ãäœçšãšå¯äœçš
ããžãã¹ãªã®ãä¿¡ãããã®ã
ç§åŠç¬¬äžïŒ
ã³ã¡ã³ãæ¬ãå°ç
ã³ã¡ã³ãæ¬
ãã¡ãïœð©IVMãæ ¹çµ¶ãããã€ããã ãªã
æ¯æãåäººèŒžå ¥ããŠåèãããã
æ¥æ¬æ¿åºã£ãŠã人ã®å¿æã£ãŠãã®ããªïŒæ¬åœã«äººéïŒ
èªæ°å ãæ ¹çµ¶ãããâïž
#
æ¯æãåäººèŒžå ¥ããŠåèãããã
æ¥æ¬æ¿åºã£ãŠã人ã®å¿æã£ãŠãã®ããªïŒæ¬åœã«äººéïŒ
èªæ°å ãæ ¹çµ¶ãããâïž
#
ä»æ¥ã®æããã®åŠšå®³èšäºèªãã ãã©
çã®ã³ã¡ã³ãæ¬ãèŠãŠãããšãããïŒ
ã¿ããªããŒããã£ãšãïŒããããŒãïŒ
ãŸãç§åŠçæ ¹æ ã¯ãªãããšèšãæ ¹æ ã
瀺ãã£ãŠè©±ã ããªïŒïœ
çã®ã³ã¡ã³ãæ¬ãèŠãŠãããšãããïŒ
ã¿ããªããŒããã£ãšãïŒããããŒãïŒ
ãŸãç§åŠçæ ¹æ ã¯ãªãããšèšãæ ¹æ ã
瀺ãã£ãŠè©±ã ããªïŒïœ
äžæãªå人茞å
¥ãšãæ··ãç©ããããã ããªãããšã€ãã³ã¡æ¬ãå°çéããã
ãã®èšäºã®å
容ã¯æ£åžžãªãã ãã©ãã³ã¡ã³ãæ¬ãã€ãã«ã¡ã¯ãã³æ¯æè
ïŒoråã¯ã¯ãã³ïŒã§åãŸã£ãŠãŠãªããªãæããã
ãã¬ããããã¶ããã®
è¿äºãé¢çœã件
è¿äºãé¢çœã件
ã€ãã³ã¡çžå€ããããã°ãããŠç¬ã
ïŒå°é家ã¯ãå人茞å
¥ã§ã®æçšã¯ããªãããã«ããšèŠéã鳎ãããŠãã
èªç§°å°é家ããããããããããã®èšäºãéµåã¿ã«ããªã
ã³ã¡æ¬1ããŒãžç®ããèŠãŠãªãããã®äººéãšåæ
èªç§°å°é家ããããããããããã®èšäºãéµåã¿ã«ããªã
ã³ã¡æ¬1ããŒãžç®ããèŠãŠãªãããã®äººéãšåæ
æ°åã³ãããŠã€ã«ã¹ã®ææäºé²ãæ²»çãç®çã«ãåœå
ã§æ¿èªãããŠããªãæå¯çè«è¬ãã€ãã«ã¡ã¯ãã³ããæµ·å€ããå人茞å
¥ããŠäœ¿çšããåããåºãã£ãŠããã
ç§åŠè
ã¯å°é£ãã説æããŸãããç°¡åã«èšãã°ãåã®äžã«ãã埮çç©ãã«ãã®äžçš®ã§ãã
ã€ãã«ã¡ã¯ãã³ãç°¡åã«èšãã°ãã¹ããã€ã
ã«ããäœå ã«å ¥ããã®ã ããé«éœ¢è ã¯å¯äœçšãåºãã
ã€ãã«ã¡ã¯ãã³ãç°¡åã«èšãã°ãã¹ããã€ã
ã«ããäœå ã«å ¥ããã®ã ããé«éœ¢è ã¯å¯äœçšãåºãã
ã€ãã«ã¡ã¯ãã³ãã»ããšã«COVID-19ã«å¹æãããªãããã®è£œè¬äŒç€Ÿãçµå£è¬äœã£ããããªãã ããã«ã
(æ°åã³ããã®çµå£è¬ã§ããã¢ã«ããã©ãã«ããã€ãã«ã¡ã¯ãã³ããã¡ã«ã¯ãšãã補è¬äŒç€Ÿãäœã£ãŠã)
(æ°åã³ããã®çµå£è¬ã§ããã¢ã«ããã©ãã«ããã€ãã«ã¡ã¯ãã³ããã¡ã«ã¯ãšãã補è¬äŒç€Ÿãäœã£ãŠã)
å»åŠçãè¬åŠçãªç¥èã¯æããªãèªç§°ã€ãã«ã¡ã¯ãã³å°é家(ç¬)ã ãã
çŽ äººãäœãšèšããããã€ãã«ã¡ã¯ãã³å®å šè¯å®æŽŸã¯å»çåŸäºè ã®äžã§ã¯ãã€ããªãã£
ãããå šãŠãè¡šããŠããã®ã«æ°ã¥ãã¹ã
çŽ äººãäœãšèšããããã€ãã«ã¡ã¯ãã³å®å šè¯å®æŽŸã¯å»çåŸäºè ã®äžã§ã¯ãã€ããªãã£
ãããå šãŠãè¡šããŠããã®ã«æ°ã¥ãã¹ã
m RNAã®èšåºæ²»éšçµæã¯ãã€åºãã®ïŒ
ãã®ç£çµã®æ¶æž¬èšäºãããã€ãã³ã¡æ¬ã®æ¹ã
ã®æ¹ãè«ççã§è©³ãããŠç¬ããð€£ð€£ð€£
ã€ãã«ã¡ã¯ãã³
誀ã£ãç§åŠãçãã
æ°åãŠã€ã«ã¹ç¹å¹è¬
BBC 2021.10.9
ã€ãã«ã¡ã¯ãã³
é倧ãªå¯äœçšã«æèé害
ååŽçã3件ã®æ·»ææ¹èšæ瀺
10.12 æ¥åè¬æ¥
ç§åŠçæ ¹æ ãªã
10.17ç£çµæ°è
誀ã£ãç§åŠãçãã
æ°åãŠã€ã«ã¹ç¹å¹è¬
BBC 2021.10.9
ã€ãã«ã¡ã¯ãã³
é倧ãªå¯äœçšã«æèé害
ååŽçã3件ã®æ·»ææ¹èšæ瀺
10.12 æ¥åè¬æ¥
ç§åŠçæ ¹æ ãªã
10.17ç£çµæ°è
ã€ããŒã³ã¡ã³ãã¯ã€ãã«ã¡ã¯ãã³æ¯æè
äžè²
ãããŠã€ããŒã¯ãªã«ãããªãã§PV皌ã
ãããŠã€ããŒã¯ãªã«ãããªãã§PV皌ã
ãã®éãã§ãïŒ
ïŸïœ§ïœ²ïœ»ïŸïœ°ãïŸïŸïŸïŸïœžïŸïŸãšå
šãåæåã®ïœºïŸïŸ
æ°è¬ãååå€ããŠ(ïŸïœ§ïœ²ïœ»ïŸïœ°ïŸïœžïŸïŸ)é«å€è²©å£²ãçãã,ãã®ç£çµã®æªæå ±éã¯æ¬ç©å®äŸ¡ïœ²ïŸïŸïŸïŸïœžïŸïŸè³Œå
¥ãžã®æãããªåŠšå®³ã®æå³ã
ïŸïŸïŸïŸïœžïŸïŸãæ¬åœã«ïœºïŸïŸ äºé²æ²»çå¹ææã®èšŒæãè³¢æãªäººã¯ãããç解ã
ïŸïŸïŸïŸïœžïŸïŸãæ¬åœã«ïœºïŸïŸ äºé²æ²»çå¹ææã®èšŒæãè³¢æãªäººã¯ãããç解ã
æ²»éšãäžååãªã³ããæ çããããå®å
šãªçµå£è¬ãæ±ããããŠãäºãèããŠæ¬²ããããã€ãã«ã¡ã¯ãã³ã¯å®å
šãå®äŸ¡ã ãããæ¥çã®æ¹ãã¡ã®éå²ãã«ãªããªããã ããå察ããã®ã§ãããïŒ
åã€ãã§ãŒãww
32ã«åœã§å®çžŸãããŸãŒãww
32ã«åœã§å®çžŸãããŸãŒãww
ãã®è¬ã¯ããããããè«äžããã§ãããæ°åã³ããã®æ²»çè¬ã§ã¯ãããŸãã
ç®çå€ã®çšéã§ãå»åž«ã®èšºå¯ïŒåŠæ¹ãåããã«æçšããã®ã¯ãå šããªã¹ã¹ã¡ã§ããŸãã
æªãã話ã«ãè¿å¯ã£ãŠã¯é§ç®
ç®çå€ã®çšéã§ãå»åž«ã®èšºå¯ïŒåŠæ¹ãåããã«æçšããã®ã¯ãå šããªã¹ã¹ã¡ã§ããŸãã
æªãã話ã«ãè¿å¯ã£ãŠã¯é§ç®
æå¹æ§ã確èªãããŠããªãã®ã«äœ¿çšãæ±ãããæ±äº¬éœå»åž«äŒããæ¬åœã«åœ¹ç«ããã ã
ãã¡ã€ã¶ãŒãã€ãã«ã¡ã¯ãã³ãšå
šãåãæåã®ã³ããæ°è¬ãååãå€ããŠ(ãã¡ã€ã¶ãŒã¡ã¯ãã³ãšæ¶æ)è¶
é«å€ã§è²©å£²ãçã£ãŠããã,ãã®ç£çµã®æªæååå ±éã¯æ¢åæ¬ç©å®äŸ¡ã€ãã«ã¡ã¯ãã³è³Œå
¥ãžã®æãããªåŠšå®³ã®æå³ãã¿ãã¿ããè³¢æãªäººã¯ãããªå ±éã¯ç¡èŠããŠããã§ããããã©ã
èŠéãªããçç±ã¯äœã§ããïŒ
ãªãã§ãè¯ãããè¬ããšããæ£è
ã«ã¯ã¬ã¡ãã£ã§ã飲ãŸããšãããšèšã£ãã®ã¯ãã€ãã³ã²ãŒã«
å㞠次ãž
å°é家ã ãïŒ
ããããããTVåºãŠè¬å±ããå ±é ¬è²°ã£ãŠãè¥æºæ°å³ãªãã®äººããã®äººã®ããšããªïŒ